Clinical Drug Testing in Primary Care (3 hours)

Categories: Drug Testing
Learning Objectives

Upon completion of this course, participants will be able to:

• Distinguish between drug screening tests and confirmatory testing methods used in primary care settings.
• Describe the window of detection, cutoff concentrations, and cross-reactivity factors that affect clinical drug testing results.
• Compare point-of-care testing with laboratory-based testing, including the advantages and limitations of each approach.
• Apply clinical drug testing procedures to monitor prescription medication use and manage chronic pain with opioids.
• Identify indicators of substance use disorders through drug testing and clinical assessment in primary care patients.
• Explain confidentiality requirements and legal considerations associated with clinical drug testing in primary care settings.

John Tinsley

John Tinsley

Ph.D.

Dr. John H. Tinsley is a former assistant professor of Medical Physiology at the Texas A&M University System College of Medicine. He received his Ph.D. from Texas A&M University, College Station, Texas; M.S. from the University of North Carolina; and his B.S. from the University of Oklahoma.

He has been teaching, training, consulting and conducting research in the fields of Medical Physiology and Behavioral Biology for over twenty-nine years. Dr. Tinsley has authored over twenty-five professional and refereed articles, including invited reviews. He has been a member of the American Society for Physiology, and work done in 2001 led to an international award from The European Society on Microcirculation. Dr. Tinsley has received research funding from the Veteran’s Administration, American Heart Association, and Scott and White Hospital. In addition, he has served on numerous review committees for national grant-funding agencies and scientific journals.

Approved and Widely Recognized

CEU Matrix is approved by the following national and state accreditation boards:

Provider #6310
Provider #94564

CEU Matrix is approved with the following state boards:

Arkansas (ASACB), California (CCAPP #OS-07-394-0222), California (CADTP #250), Connecticut (#0115-5202), Delaware (DCB #37), Florida (FCB #5141-A), Georgia (ADACBGA #2026-4-003), Illinois (IAODAPCA #19345), Kentucky, Louisiana (LA ADRA #E026), Michigan (MCBAP), Missouri (Missouri CB #183), New Mexico (NMCBBHP #2046), North Carolina (NCSAPPB), Ohio (OCDP #50-19236), Oklahoma (OBLADS #20260153), Texas (TCB #1758-07)

Scroll to Top